First for Women on MSN27d
La La Anthony on Her Plaque Psoriasis: ‘It Doesn't Have To Hold You Back'"I would come out of the shower and still have flakes on my scalp, and was confused because I had just washed my hair." The ...
It most commonly develops on the: knees elbows scalp trunk Psoriasis can affect ... psoriasis on your feet and how it can be treated. Plaque psoriasis is the most common type of psoriasis.
Recent study findings highlight the value of integrating behavioral modification and Health Belief Model–based education into ...
Topline results from Phase 3 ICONIC-ADVANCE 1&2�studies show icotrokinra achieved co-primary endpoints and showed superiority to deucravacitinib in moderate-to-severe plaque PsO ...
Posters presented at the 2025 American Academy of Dermatology Annual Meeting found tildrakizumab outcomes to have a mean drug ...
Post-hoc analyses of the EFFISAYIL 2 trial revealed improvements in Psoriasis Symptom Scale (PSS), Pain Visual Analog Scale ...
Its lead asset, SFA-002, an IL-10 up-regulator in immune cells, is approaching Phase 2 clinical trial and has shown promising Phase 1a and Phase 1b results for the treatment of plaque psoriasis.
Risankizumab was associated with more significant improvements among patients with plaque psoriasis when compared with other biologic therapies.
viii Clinicaltrials.gov. A study of JNJ-2113 for the treatment of participants with plaque psoriasis involving special areas (scalp, genital, and/or palms of the hands and the soles of the feet ...
Nearly half of patients with moderate-to-severe plaque psoriasis (PsO) treated with icotrokinra achieved completely clear skin (IGA 0) at Week 24 in Phase 3 ICONIC-LEAD study Topline results from ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results